The Board of Directors of the Ideas x Innovation Network announced the newest board member to join their ranks last month: Reginald Motley, CMC Leader, Global R&D Operations & Biosimilars at Teva USA, a large generics pharmaceutical company, in West Chester, PA. His expertise in the areas of conceptual development through commercialization will be an asset to i2n entrepreneurs and early-stage companies as they develop their products and seek funding.
“We are proud to welcome Reggie to the i2n board of directors and look forward to working with him and Teva on our mission of advancing innovation & entrepreneurship in southeast PA,” stated Michael Harrington, i2n co-chair and partner at Fox Rothschild.
At Teva, Motley leads cross-functional biologics product development programs, from drug product development to commercialization/launch to market. His background also includes participation as a business proposal reviewer within the University City Science Center in Philadelphia.
“i2n is all about providing early-stage and advanced technology companies the resources they need to grow—whether it’s funding, workspace, industry expertise, or key business connections. Reggie brings a wealth of knowledge and real passion for innovation in life sciences that will be a tremendous asset to our network,” says Patrick Hayakawa, VP of Innovation & Marketing at CCEDC and director of the i2n program. “Teva has long been an anchor employer for the region and a global leader in life sciences. CCEDC and i2n are proud to partner with them. Our all-volunteer board has been crucial to i2n’s growth and long-term success.”
Motley has extensive experience in product lifecycle management from conceptual development through design development to commercialization, focused on biologics, utilizing drug delivery systems and medical devices. He has a B.S. in Mechanical Engineering from Carnegie Mellon University and a M.S. in Systems Engineering from Penn State University – Great Valley campus.
Since its formation in 2012, i2n client companies have raised hundreds of millions of dollars in grants and venture capital, leading to over a thousand jobs created and significant economic impacts for southeastern PA.